nodes	percent_of_prediction	percent_of_DWPC	metapath
Tizanidine—NISCH—Paclitaxel—Docetaxel—head and neck cancer	0.0367	0.645	CbGdCrCtD
Tizanidine—Skin cancer—Hydroxyurea—head and neck cancer	0.0338	0.0363	CcSEcCtD
Tizanidine—NISCH—Vincristine—Vinblastine—head and neck cancer	0.0202	0.355	CbGdCrCtD
Tizanidine—Developmental delay—Fluorouracil—head and neck cancer	0.0199	0.0213	CcSEcCtD
Tizanidine—Congenital anomaly—Fluorouracil—head and neck cancer	0.0199	0.0213	CcSEcCtD
Tizanidine—Disseminated intravascular coagulation—Docetaxel—head and neck cancer	0.0153	0.0164	CcSEcCtD
Tizanidine—Hepatotoxicity—Hydroxyurea—head and neck cancer	0.0136	0.0146	CcSEcCtD
Tizanidine—Skin ulcer—Hydroxyurea—head and neck cancer	0.0135	0.0145	CcSEcCtD
Tizanidine—Cellulitis—Vinblastine—head and neck cancer	0.0127	0.0136	CcSEcCtD
Tizanidine—Clonidine—CYP1A1—head and neck cancer	0.011	1	CrCbGaD
Tizanidine—Phlebitis—Vinblastine—head and neck cancer	0.00969	0.0104	CcSEcCtD
Tizanidine—Foetor hepaticus—Docetaxel—head and neck cancer	0.00961	0.0103	CcSEcCtD
Tizanidine—Pulmonary oedema—Hydroxyurea—head and neck cancer	0.00934	0.01	CcSEcCtD
Tizanidine—Deafness—Vinblastine—head and neck cancer	0.00934	0.01	CcSEcCtD
Tizanidine—Speech disorder—Fluorouracil—head and neck cancer	0.00878	0.00942	CcSEcCtD
Tizanidine—Cerebrovascular accident—Vinblastine—head and neck cancer	0.00852	0.00914	CcSEcCtD
Tizanidine—Hepatic failure—Hydroxyurea—head and neck cancer	0.00848	0.00909	CcSEcCtD
Tizanidine—Cellulitis—Fluorouracil—head and neck cancer	0.00831	0.00891	CcSEcCtD
Tizanidine—Renal failure acute—Hydroxyurea—head and neck cancer	0.00825	0.00885	CcSEcCtD
Tizanidine—Herpes simplex—Fluorouracil—head and neck cancer	0.0082	0.00879	CcSEcCtD
Tizanidine—Leukocytosis—Fluorouracil—head and neck cancer	0.00804	0.00862	CcSEcCtD
Tizanidine—Intestinal obstruction—Docetaxel—head and neck cancer	0.008	0.00858	CcSEcCtD
Tizanidine—Liver disorder—Docetaxel—head and neck cancer	0.008	0.00858	CcSEcCtD
Tizanidine—Neuralgia—Docetaxel—head and neck cancer	0.00785	0.00842	CcSEcCtD
Tizanidine—Scotoma—Docetaxel—head and neck cancer	0.00718	0.0077	CcSEcCtD
Tizanidine—Hepatotoxicity—Docetaxel—head and neck cancer	0.00706	0.00757	CcSEcCtD
Tizanidine—Angina pectoris—Vinblastine—head and neck cancer	0.00703	0.00754	CcSEcCtD
Tizanidine—Otitis media—Docetaxel—head and neck cancer	0.007	0.00751	CcSEcCtD
Tizanidine—Sepsis—Fluorouracil—head and neck cancer	0.00655	0.00703	CcSEcCtD
Tizanidine—Euphoric mood—Fluorouracil—head and neck cancer	0.00649	0.00696	CcSEcCtD
Tizanidine—Depression—Vinblastine—head and neck cancer	0.00642	0.00689	CcSEcCtD
Tizanidine—Acute coronary syndrome—Vinblastine—head and neck cancer	0.00634	0.00681	CcSEcCtD
Tizanidine—Myocardial infarction—Vinblastine—head and neck cancer	0.00631	0.00677	CcSEcCtD
Tizanidine—Neuropathy peripheral—Vinblastine—head and neck cancer	0.00631	0.00677	CcSEcCtD
Tizanidine—Agranulocytosis—Vinblastine—head and neck cancer	0.00601	0.00644	CcSEcCtD
Tizanidine—Drowsiness—Hydroxyurea—head and neck cancer	0.00587	0.0063	CcSEcCtD
Tizanidine—Haemoglobin—Vinblastine—head and neck cancer	0.00581	0.00623	CcSEcCtD
Tizanidine—Haemorrhage—Vinblastine—head and neck cancer	0.00578	0.0062	CcSEcCtD
Tizanidine—Neuropathy peripheral—Hydroxyurea—head and neck cancer	0.00575	0.00617	CcSEcCtD
Tizanidine—Pharyngitis—Vinblastine—head and neck cancer	0.00573	0.00615	CcSEcCtD
Tizanidine—Cardiac failure—Fluorouracil—head and neck cancer	0.00562	0.00603	CcSEcCtD
Tizanidine—Hepatobiliary disease—Hydroxyurea—head and neck cancer	0.00555	0.00596	CcSEcCtD
Tizanidine—Gastrointestinal haemorrhage—Fluorouracil—head and neck cancer	0.00548	0.00588	CcSEcCtD
Tizanidine—Hepatocellular injury—Docetaxel—head and neck cancer	0.00545	0.00585	CcSEcCtD
Tizanidine—Pulmonary embolism—Docetaxel—head and neck cancer	0.00545	0.00585	CcSEcCtD
Tizanidine—Haemoglobin—Hydroxyurea—head and neck cancer	0.0053	0.00568	CcSEcCtD
Tizanidine—Haemorrhage—Hydroxyurea—head and neck cancer	0.00527	0.00565	CcSEcCtD
Tizanidine—Hallucination—Hydroxyurea—head and neck cancer	0.00524	0.00562	CcSEcCtD
Tizanidine—Cardiac arrest—Fluorouracil—head and neck cancer	0.00521	0.00559	CcSEcCtD
Tizanidine—Candida infection—Docetaxel—head and neck cancer	0.0052	0.00558	CcSEcCtD
Tizanidine—Neuropathy—Docetaxel—head and neck cancer	0.00512	0.00549	CcSEcCtD
Tizanidine—Alopecia—Vinblastine—head and neck cancer	0.00511	0.00548	CcSEcCtD
Tizanidine—Dry skin—Fluorouracil—head and neck cancer	0.00503	0.00539	CcSEcCtD
Tizanidine—Pulmonary oedema—Docetaxel—head and neck cancer	0.00485	0.00521	CcSEcCtD
Tizanidine—Muscular weakness—Fluorouracil—head and neck cancer	0.00484	0.00519	CcSEcCtD
Tizanidine—Angiopathy—Hydroxyurea—head and neck cancer	0.00478	0.00513	CcSEcCtD
Tizanidine—Dysphagia—Fluorouracil—head and neck cancer	0.00474	0.00508	CcSEcCtD
Tizanidine—Sepsis—Docetaxel—head and neck cancer	0.00473	0.00508	CcSEcCtD
Tizanidine—Ill-defined disorder—Vinblastine—head and neck cancer	0.00467	0.00501	CcSEcCtD
Tizanidine—Alopecia—Hydroxyurea—head and neck cancer	0.00466	0.005	CcSEcCtD
Tizanidine—Anaemia—Vinblastine—head and neck cancer	0.00465	0.00499	CcSEcCtD
Tizanidine—Angina pectoris—Fluorouracil—head and neck cancer	0.00462	0.00495	CcSEcCtD
Tizanidine—Phlebitis—Docetaxel—head and neck cancer	0.00459	0.00493	CcSEcCtD
Tizanidine—Malaise—Vinblastine—head and neck cancer	0.00454	0.00487	CcSEcCtD
Tizanidine—Vertigo—Vinblastine—head and neck cancer	0.00452	0.00485	CcSEcCtD
Tizanidine—Leukopenia—Vinblastine—head and neck cancer	0.0045	0.00483	CcSEcCtD
Tizanidine—Deafness—Docetaxel—head and neck cancer	0.00442	0.00475	CcSEcCtD
Tizanidine—Hepatic failure—Docetaxel—head and neck cancer	0.0044	0.00472	CcSEcCtD
Tizanidine—Convulsion—Vinblastine—head and neck cancer	0.00436	0.00468	CcSEcCtD
Tizanidine—Hypertension—Vinblastine—head and neck cancer	0.00434	0.00466	CcSEcCtD
Tizanidine—Ill-defined disorder—Hydroxyurea—head and neck cancer	0.00426	0.00457	CcSEcCtD
Tizanidine—Pneumonia—Fluorouracil—head and neck cancer	0.00425	0.00456	CcSEcCtD
Tizanidine—Anaemia—Hydroxyurea—head and neck cancer	0.00424	0.00455	CcSEcCtD
Tizanidine—Discomfort—Vinblastine—head and neck cancer	0.00423	0.00454	CcSEcCtD
Tizanidine—Acute coronary syndrome—Fluorouracil—head and neck cancer	0.00416	0.00447	CcSEcCtD
Tizanidine—Myocardial infarction—Fluorouracil—head and neck cancer	0.00414	0.00444	CcSEcCtD
Tizanidine—Neuropathy peripheral—Fluorouracil—head and neck cancer	0.00414	0.00444	CcSEcCtD
Tizanidine—Malaise—Hydroxyurea—head and neck cancer	0.00414	0.00444	CcSEcCtD
Tizanidine—Conjunctivitis—Fluorouracil—head and neck cancer	0.00411	0.00441	CcSEcCtD
Tizanidine—Leukopenia—Hydroxyurea—head and neck cancer	0.00411	0.00441	CcSEcCtD
Tizanidine—Cardiac failure—Docetaxel—head and neck cancer	0.00405	0.00435	CcSEcCtD
Tizanidine—Thrombocytopenia—Vinblastine—head and neck cancer	0.00402	0.00431	CcSEcCtD
Tizanidine—Convulsion—Hydroxyurea—head and neck cancer	0.00397	0.00426	CcSEcCtD
Tizanidine—Hyponatraemia—Docetaxel—head and neck cancer	0.00397	0.00426	CcSEcCtD
Tizanidine—Sinusitis—Fluorouracil—head and neck cancer	0.00396	0.00425	CcSEcCtD
Tizanidine—Gastrointestinal haemorrhage—Docetaxel—head and neck cancer	0.00396	0.00425	CcSEcCtD
Tizanidine—Agranulocytosis—Fluorouracil—head and neck cancer	0.00394	0.00423	CcSEcCtD
Tizanidine—Migraine—Docetaxel—head and neck cancer	0.00389	0.00418	CcSEcCtD
Tizanidine—Unspecified disorder of skin and subcutaneous tissue—Hydroxyurea—head and neck cancer	0.00388	0.00416	CcSEcCtD
Tizanidine—Discomfort—Hydroxyurea—head and neck cancer	0.00386	0.00414	CcSEcCtD
Tizanidine—Haemoglobin—Fluorouracil—head and neck cancer	0.00381	0.00409	CcSEcCtD
Tizanidine—Rhinitis—Fluorouracil—head and neck cancer	0.0038	0.00408	CcSEcCtD
Tizanidine—Haemorrhage—Fluorouracil—head and neck cancer	0.00379	0.00407	CcSEcCtD
Tizanidine—Pharyngitis—Fluorouracil—head and neck cancer	0.00376	0.00404	CcSEcCtD
Tizanidine—Oedema—Hydroxyurea—head and neck cancer	0.00374	0.00402	CcSEcCtD
Tizanidine—Infection—Hydroxyurea—head and neck cancer	0.00372	0.00399	CcSEcCtD
Tizanidine—Paraesthesia—Vinblastine—head and neck cancer	0.00369	0.00395	CcSEcCtD
Tizanidine—Nervous system disorder—Hydroxyurea—head and neck cancer	0.00367	0.00394	CcSEcCtD
Tizanidine—Thrombocytopenia—Hydroxyurea—head and neck cancer	0.00367	0.00393	CcSEcCtD
Tizanidine—Liver function test abnormal—Docetaxel—head and neck cancer	0.00365	0.00392	CcSEcCtD
Tizanidine—Skin disorder—Hydroxyurea—head and neck cancer	0.00364	0.0039	CcSEcCtD
Tizanidine—Dry skin—Docetaxel—head and neck cancer	0.00363	0.00389	CcSEcCtD
Tizanidine—Orthostatic hypotension—Docetaxel—head and neck cancer	0.00361	0.00388	CcSEcCtD
Tizanidine—Constipation—Vinblastine—head and neck cancer	0.00351	0.00377	CcSEcCtD
Tizanidine—Alanine aminotransferase increased—Docetaxel—head and neck cancer	0.00349	0.00374	CcSEcCtD
Tizanidine—Dysphagia—Docetaxel—head and neck cancer	0.00342	0.00367	CcSEcCtD
Tizanidine—Arrhythmia—Fluorouracil—head and neck cancer	0.00339	0.00364	CcSEcCtD
Tizanidine—Feeling abnormal—Vinblastine—head and neck cancer	0.00338	0.00363	CcSEcCtD
Tizanidine—Gastrointestinal pain—Vinblastine—head and neck cancer	0.00336	0.0036	CcSEcCtD
Tizanidine—Alopecia—Fluorouracil—head and neck cancer	0.00335	0.0036	CcSEcCtD
Tizanidine—Dyspnoea—Hydroxyurea—head and neck cancer	0.00334	0.00358	CcSEcCtD
Tizanidine—Angina pectoris—Docetaxel—head and neck cancer	0.00333	0.00357	CcSEcCtD
Tizanidine—Somnolence—Hydroxyurea—head and neck cancer	0.00333	0.00357	CcSEcCtD
Tizanidine—Dyspepsia—Hydroxyurea—head and neck cancer	0.0033	0.00354	CcSEcCtD
Tizanidine—Abdominal pain—Vinblastine—head and neck cancer	0.00325	0.00348	CcSEcCtD
Tizanidine—Fatigue—Hydroxyurea—head and neck cancer	0.00323	0.00346	CcSEcCtD
Tizanidine—Constipation—Hydroxyurea—head and neck cancer	0.0032	0.00343	CcSEcCtD
Tizanidine—Vision blurred—Fluorouracil—head and neck cancer	0.00311	0.00334	CcSEcCtD
Tizanidine—Weight decreased—Docetaxel—head and neck cancer	0.00309	0.00332	CcSEcCtD
Tizanidine—Feeling abnormal—Hydroxyurea—head and neck cancer	0.00308	0.00331	CcSEcCtD
Tizanidine—Pneumonia—Docetaxel—head and neck cancer	0.00307	0.00329	CcSEcCtD
Tizanidine—Anaemia—Fluorouracil—head and neck cancer	0.00305	0.00327	CcSEcCtD
Tizanidine—Hypersensitivity—Vinblastine—head and neck cancer	0.00302	0.00324	CcSEcCtD
Tizanidine—Stevens-Johnson syndrome—Docetaxel—head and neck cancer	0.00302	0.00324	CcSEcCtD
Tizanidine—Acute coronary syndrome—Docetaxel—head and neck cancer	0.00301	0.00323	CcSEcCtD
Tizanidine—Renal failure—Docetaxel—head and neck cancer	0.003	0.00322	CcSEcCtD
Tizanidine—Myocardial infarction—Docetaxel—head and neck cancer	0.00299	0.00321	CcSEcCtD
Tizanidine—Neuropathy peripheral—Docetaxel—head and neck cancer	0.00299	0.00321	CcSEcCtD
Tizanidine—Jaundice—Docetaxel—head and neck cancer	0.00297	0.00319	CcSEcCtD
Tizanidine—Conjunctivitis—Docetaxel—head and neck cancer	0.00296	0.00318	CcSEcCtD
Tizanidine—Body temperature increased—Hydroxyurea—head and neck cancer	0.00296	0.00317	CcSEcCtD
Tizanidine—Leukopenia—Fluorouracil—head and neck cancer	0.00296	0.00317	CcSEcCtD
Tizanidine—Asthenia—Vinblastine—head and neck cancer	0.00295	0.00316	CcSEcCtD
Tizanidine—Hepatobiliary disease—Docetaxel—head and neck cancer	0.00288	0.00309	CcSEcCtD
Tizanidine—Convulsion—Fluorouracil—head and neck cancer	0.00286	0.00307	CcSEcCtD
Tizanidine—Agranulocytosis—Docetaxel—head and neck cancer	0.00285	0.00305	CcSEcCtD
Tizanidine—Diarrhoea—Vinblastine—head and neck cancer	0.00281	0.00301	CcSEcCtD
Tizanidine—Discomfort—Fluorouracil—head and neck cancer	0.00278	0.00298	CcSEcCtD
Tizanidine—Hypersensitivity—Hydroxyurea—head and neck cancer	0.00276	0.00296	CcSEcCtD
Tizanidine—Haemoglobin—Docetaxel—head and neck cancer	0.00275	0.00295	CcSEcCtD
Tizanidine—Rhinitis—Docetaxel—head and neck cancer	0.00274	0.00294	CcSEcCtD
Tizanidine—Hepatitis—Docetaxel—head and neck cancer	0.00274	0.00294	CcSEcCtD
Tizanidine—Haemorrhage—Docetaxel—head and neck cancer	0.00274	0.00294	CcSEcCtD
Tizanidine—Confusional state—Fluorouracil—head and neck cancer	0.00272	0.00291	CcSEcCtD
Tizanidine—Pharyngitis—Docetaxel—head and neck cancer	0.00272	0.00291	CcSEcCtD
Tizanidine—Dizziness—Vinblastine—head and neck cancer	0.00271	0.00291	CcSEcCtD
Tizanidine—Urinary tract disorder—Docetaxel—head and neck cancer	0.0027	0.0029	CcSEcCtD
Tizanidine—Anaphylactic shock—Fluorouracil—head and neck cancer	0.00269	0.00289	CcSEcCtD
Tizanidine—Oedema—Fluorouracil—head and neck cancer	0.00269	0.00289	CcSEcCtD
Tizanidine—Connective tissue disorder—Docetaxel—head and neck cancer	0.00269	0.00289	CcSEcCtD
Tizanidine—Asthenia—Hydroxyurea—head and neck cancer	0.00269	0.00288	CcSEcCtD
Tizanidine—Urethral disorder—Docetaxel—head and neck cancer	0.00268	0.00288	CcSEcCtD
Tizanidine—Infection—Fluorouracil—head and neck cancer	0.00268	0.00287	CcSEcCtD
Tizanidine—Nervous system disorder—Fluorouracil—head and neck cancer	0.00264	0.00284	CcSEcCtD
Tizanidine—Thrombocytopenia—Fluorouracil—head and neck cancer	0.00264	0.00283	CcSEcCtD
Tizanidine—Tachycardia—Fluorouracil—head and neck cancer	0.00263	0.00282	CcSEcCtD
Tizanidine—Vomiting—Vinblastine—head and neck cancer	0.00261	0.0028	CcSEcCtD
Tizanidine—Erythema multiforme—Docetaxel—head and neck cancer	0.00259	0.00278	CcSEcCtD
Tizanidine—Diarrhoea—Hydroxyurea—head and neck cancer	0.00256	0.00275	CcSEcCtD
Tizanidine—Cardiac disorder—Docetaxel—head and neck cancer	0.00254	0.00273	CcSEcCtD
Tizanidine—Hypotension—Fluorouracil—head and neck cancer	0.00252	0.0027	CcSEcCtD
Tizanidine—Angiopathy—Docetaxel—head and neck cancer	0.00248	0.00266	CcSEcCtD
Tizanidine—Dizziness—Hydroxyurea—head and neck cancer	0.00248	0.00266	CcSEcCtD
Tizanidine—Immune system disorder—Docetaxel—head and neck cancer	0.00247	0.00265	CcSEcCtD
Tizanidine—Mediastinal disorder—Docetaxel—head and neck cancer	0.00247	0.00265	CcSEcCtD
Tizanidine—Musculoskeletal discomfort—Fluorouracil—head and neck cancer	0.00245	0.00263	CcSEcCtD
Tizanidine—Arrhythmia—Docetaxel—head and neck cancer	0.00245	0.00262	CcSEcCtD
Tizanidine—Nausea—Vinblastine—head and neck cancer	0.00244	0.00262	CcSEcCtD
Tizanidine—Paraesthesia—Fluorouracil—head and neck cancer	0.00242	0.0026	CcSEcCtD
Tizanidine—Alopecia—Docetaxel—head and neck cancer	0.00242	0.0026	CcSEcCtD
Tizanidine—Dyspnoea—Fluorouracil—head and neck cancer	0.0024	0.00258	CcSEcCtD
Tizanidine—Mental disorder—Docetaxel—head and neck cancer	0.0024	0.00257	CcSEcCtD
Tizanidine—Somnolence—Fluorouracil—head and neck cancer	0.0024	0.00257	CcSEcCtD
Tizanidine—Vomiting—Hydroxyurea—head and neck cancer	0.00238	0.00255	CcSEcCtD
Tizanidine—Dyspepsia—Fluorouracil—head and neck cancer	0.00237	0.00254	CcSEcCtD
Tizanidine—Rash—Hydroxyurea—head and neck cancer	0.00236	0.00253	CcSEcCtD
Tizanidine—Dermatitis—Hydroxyurea—head and neck cancer	0.00236	0.00253	CcSEcCtD
Tizanidine—Back pain—Docetaxel—head and neck cancer	0.00231	0.00247	CcSEcCtD
Tizanidine—Muscle spasms—Docetaxel—head and neck cancer	0.00229	0.00246	CcSEcCtD
Tizanidine—Nausea—Hydroxyurea—head and neck cancer	0.00222	0.00239	CcSEcCtD
Tizanidine—Feeling abnormal—Fluorouracil—head and neck cancer	0.00222	0.00238	CcSEcCtD
Tizanidine—Anaemia—Docetaxel—head and neck cancer	0.0022	0.00236	CcSEcCtD
Tizanidine—Urticaria—Fluorouracil—head and neck cancer	0.00214	0.0023	CcSEcCtD
Tizanidine—Syncope—Docetaxel—head and neck cancer	0.00214	0.00229	CcSEcCtD
Tizanidine—Leukopenia—Docetaxel—head and neck cancer	0.00213	0.00229	CcSEcCtD
Tizanidine—Body temperature increased—Fluorouracil—head and neck cancer	0.00213	0.00229	CcSEcCtD
Tizanidine—Loss of consciousness—Docetaxel—head and neck cancer	0.00209	0.00225	CcSEcCtD
Tizanidine—Convulsion—Docetaxel—head and neck cancer	0.00206	0.00222	CcSEcCtD
Tizanidine—Hypertension—Docetaxel—head and neck cancer	0.00206	0.00221	CcSEcCtD
Tizanidine—Arthralgia—Docetaxel—head and neck cancer	0.00203	0.00218	CcSEcCtD
Tizanidine—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—head and neck cancer	0.00201	0.00216	CcSEcCtD
Tizanidine—Hypersensitivity—Fluorouracil—head and neck cancer	0.00199	0.00213	CcSEcCtD
Tizanidine—Dry mouth—Docetaxel—head and neck cancer	0.00198	0.00213	CcSEcCtD
Tizanidine—Confusional state—Docetaxel—head and neck cancer	0.00196	0.0021	CcSEcCtD
Tizanidine—Anaphylactic shock—Docetaxel—head and neck cancer	0.00194	0.00209	CcSEcCtD
Tizanidine—Oedema—Docetaxel—head and neck cancer	0.00194	0.00209	CcSEcCtD
Tizanidine—Infection—Docetaxel—head and neck cancer	0.00193	0.00207	CcSEcCtD
Tizanidine—Shock—Docetaxel—head and neck cancer	0.00191	0.00205	CcSEcCtD
Tizanidine—Nervous system disorder—Docetaxel—head and neck cancer	0.00191	0.00205	CcSEcCtD
Tizanidine—Pruritus—Fluorouracil—head and neck cancer	0.00191	0.00205	CcSEcCtD
Tizanidine—Thrombocytopenia—Docetaxel—head and neck cancer	0.0019	0.00204	CcSEcCtD
Tizanidine—Tachycardia—Docetaxel—head and neck cancer	0.0019	0.00204	CcSEcCtD
Tizanidine—Skin disorder—Docetaxel—head and neck cancer	0.00189	0.00203	CcSEcCtD
Tizanidine—Diarrhoea—Fluorouracil—head and neck cancer	0.00184	0.00198	CcSEcCtD
Tizanidine—Hypotension—Docetaxel—head and neck cancer	0.00182	0.00195	CcSEcCtD
Tizanidine—Dizziness—Fluorouracil—head and neck cancer	0.00178	0.00191	CcSEcCtD
Tizanidine—Musculoskeletal discomfort—Docetaxel—head and neck cancer	0.00177	0.0019	CcSEcCtD
Tizanidine—Paraesthesia—Docetaxel—head and neck cancer	0.00175	0.00187	CcSEcCtD
Tizanidine—Dyspnoea—Docetaxel—head and neck cancer	0.00173	0.00186	CcSEcCtD
Tizanidine—Somnolence—Docetaxel—head and neck cancer	0.00173	0.00185	CcSEcCtD
Tizanidine—Vomiting—Fluorouracil—head and neck cancer	0.00171	0.00184	CcSEcCtD
Tizanidine—Dyspepsia—Docetaxel—head and neck cancer	0.00171	0.00184	CcSEcCtD
Tizanidine—Rash—Fluorouracil—head and neck cancer	0.0017	0.00182	CcSEcCtD
Tizanidine—Dermatitis—Fluorouracil—head and neck cancer	0.0017	0.00182	CcSEcCtD
Tizanidine—Fatigue—Docetaxel—head and neck cancer	0.00168	0.0018	CcSEcCtD
Tizanidine—Constipation—Docetaxel—head and neck cancer	0.00166	0.00178	CcSEcCtD
Tizanidine—Feeling abnormal—Docetaxel—head and neck cancer	0.0016	0.00172	CcSEcCtD
Tizanidine—Nausea—Fluorouracil—head and neck cancer	0.0016	0.00172	CcSEcCtD
Tizanidine—Gastrointestinal pain—Docetaxel—head and neck cancer	0.00159	0.00171	CcSEcCtD
Tizanidine—Abdominal pain—Docetaxel—head and neck cancer	0.00154	0.00165	CcSEcCtD
Tizanidine—Body temperature increased—Docetaxel—head and neck cancer	0.00154	0.00165	CcSEcCtD
Tizanidine—Hypersensitivity—Docetaxel—head and neck cancer	0.00143	0.00154	CcSEcCtD
Tizanidine—Asthenia—Docetaxel—head and neck cancer	0.0014	0.0015	CcSEcCtD
Tizanidine—Pruritus—Docetaxel—head and neck cancer	0.00138	0.00148	CcSEcCtD
Tizanidine—Diarrhoea—Docetaxel—head and neck cancer	0.00133	0.00143	CcSEcCtD
Tizanidine—Dizziness—Docetaxel—head and neck cancer	0.00129	0.00138	CcSEcCtD
Tizanidine—Vomiting—Docetaxel—head and neck cancer	0.00124	0.00133	CcSEcCtD
Tizanidine—Rash—Docetaxel—head and neck cancer	0.00123	0.00132	CcSEcCtD
Tizanidine—Dermatitis—Docetaxel—head and neck cancer	0.00123	0.00131	CcSEcCtD
Tizanidine—Nausea—Docetaxel—head and neck cancer	0.00116	0.00124	CcSEcCtD
